ANDA 75559, held by Hospira. Butorphanol Tartrate.
As of Nov 16, 2026, ANDA 75559 (Butorphanol Tartrate), held by Hospira, was first approved by FDA on Mar 20, 2000, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 20, 2000 | Original application | Approved |
| Butorphanol Tartrate1MG/ML · injectable;injection | Butorphanol Tartrate | Discontinued |
| Butorphanol Tartrate2MG/ML · injectable;injection | Butorphanol Tartrate | Discontinued |
| Aug 13, 2002 | Supplement 2Manufacturing | Approved | None posted |
| Aug 13, 2002 | Supplement 3Manufacturing | Approved | None posted |
| Aug 13, 2002 | Supplement 4Manufacturing | Approved | None posted |
| Feb 14, 2001 | Supplement 1Manufacturing | Approved | None posted |
| Mar 20, 2000 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters